Dokters Vandenplas en Verheughe, hartchirurgie en algemene geneeskunde
0589.937.469 · rovalta.com · 28/09/2026
Dokters Vandenplas en Verheughe, hartchirurgie en algemene geneeskunde
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODokters Vandenplas en Verheughe, hartchirurgie en algemene geneeskunde is a Private limited company incorporated in 2015. Its registered office is in Nazareth-De Pinte.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0589.937.469
- Incorporation
- 30/01/2015
- Legal form
- Private limited company
- Registered office
- Stijn Streuvelsstraat 16
9810 Nazareth-De Pinte · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 478,7 k € | +7.8% | 444,2 k € | -13.9% | 516,1 k € | +6.6% | 484 k € | +37.5% | 352,1 k € |
| EBITDA | 477,2 k € | +7.8% | 442,7 k € | -14.1% | 515,2 k € | +7.2% | 480,8 k € | +37.2% | 350,3 k € |
| Operating result | 452,7 k € | +6.8% | 423,9 k € | -15.0% | 498,8 k € | +7.1% | 466 k € | +40.7% | 331,1 k € |
| Net result | 356 k € | +8.3% | 328,6 k € | -21.8% | 420,4 k € | +18.5% | 354,7 k € | +38.5% | 256 k € |
| Balance sheet | |||||||||
| Equity | 462,5 k € | -9.3% | 509,7 k € | 0.0% | 509,7 k € | 0.0% | 509,7 k € | 0.0% | 509,7 k € |
| Total assets | 878,7 k € | +3.6% | 848,4 k € | -11.3% | 956,3 k € | +7.9% | 886,5 k € | -1.2% | 897,4 k € |
| Cash | 486,9 k € | +26.0% | 386,5 k € | +6.1% | 364,2 k € | -20.3% | 456,7 k € | -15.0% | 537 k € |
| Debts | 12,2 k € | +26.1% | 9,6 k € | -62.9% | 25,9 k € | +18.7% | 21,9 k € | +10.1% | 19,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Delphine Verheughe | DirectorManagerended | |
Guy Vandenplas | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/05/2026 | 10/06/2025 | 25/04/2024 | 31/05/2023 | 12/05/2022 | 15/06/2021 |
| General meeting | 18/05/2026 | 13/05/2025 | 25/04/2024 | 31/05/2023 | 12/05/2022 | 15/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 18/05/2026 | 20/05/2026 | Dutch | |
| Micro model | 31/12/2024 | 13/05/2025 | 10/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 25/04/2024 | 25/04/2024 | Dutch | |
| Micro model | 31/12/2022 | 31/05/2023 | 31/05/2023 | Dutch | |
| Micro model | 31/12/2021 | 12/05/2022 | 12/05/2022 | Dutch | |
| Micro model | 31/12/2020 | 15/06/2021 | 15/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 30/06/2020 | 06/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 25/06/2019 | 27/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 12/06/2018 | 14/06/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/06/2017 | 30/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 26/05/2016 | 26/05/2016 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Delphine Verheughe | DirectorManagerended | |
Guy Vandenplas | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Stijn Streuvelsstraat 16, 9810 Nazareth-De PinteCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00119218 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokters Vandenplas en Verheughe, hartchirurgie en algemene geneeskundeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00119218 |
Events
- 2025Annual accounts 2025356 k €↑
- 2024Annual accounts 2024328,6 k €↓
- 2023Annual accounts 2023420,4 k €↑
- 2022Annual accounts 2022354,7 k €↑
- 2021Annual accounts 2021256 k €↑
- 2020Annual accounts 2020197 k €↑
- 2019Annual accounts 2019196,6 k €↑
- 2018Annual accounts 2018158 k €↑
- 2017Annual accounts 2017136,3 k €↑
- 2016Annual accounts 2016111,7 k €↑
- 2015Annual accounts 201561,6 k €
- 30/01/2015IncorporationPrivate limited company